###begin article-title 0
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
Steroidogenic Activity of StAR Requires Contact with Mitochondrial VDAC1 and Phosphate Carrier Protein*
###end article-title 0
###begin p 1
###xml 178 204 178 204 <email xmlns:xlink="http://www.w3.org/1999/xlink">bosehi1@memorialhealth.com</email>
 To whom correspondence should be addressed: Dept. of Biomedical Sciences, Mercer University School of Medicine, 4700 Waters Ave., Savannah, GA 31404. Fax: 912-350-8998; E-mail: bosehi1@memorialhealth.com.
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
The steroidogenic acute regulatory protein (StAR) is required for adrenal and gonadal steroidogenesis and for male sexual differentiation. StAR acts on the outer mitochondrial membrane (OMM) to facilitate movement of cholesterol from the OMM to the inner mitochondrial membrane to be converted to pregnenolone, the precursor of all steroid hormones. The mechanisms of the action of StAR remain unclear; the peripheral benzodiazepine receptor, an OMM protein, appears to be involved, but the identity of OMM proteins that interact with StAR remain unknown. Here we demonstrate that phosphorylated StAR interacts with voltage-dependent anion channel 1 (VDAC1) on the OMM, which then facilitates processing of the 37-kDa phospho-StAR to the 32-kDa intermediate. In the absence of VDAC1, phospho-StAR is degraded by cysteine proteases prior to mitochondrial import. Phosphorylation of StAR by protein kinase A requires phosphate carrier protein on the OMM, which appears to interact with StAR before it interacts with VDAC1. VDAC1 and phosphate carrier protein are the first OMM proteins shown to contact StAR.
###end p 4
###begin p 5
###xml 39 45 39 45 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Pfizer</grant-sponsor>
###xml 51 65 51 65 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">March of Dimes</grant-sponsor>
###xml 71 97 71 97 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">American Heart Association</grant-sponsor>
###xml 127 158 127 158 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Howard Hughes Medical Institute</grant-sponsor>
###xml 175 204 175 204 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 211 218 211 218 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">DK37922</grant-num>
###xml 247 264 247 264 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Endocrine Society</grant-sponsor>
###xml 421 434 421 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported by grants from Pfizer, the March of Dimes, the American Heart Association, a start up package from the Howard Hughes Medical Institute (to H. B.), and National Institutes of Health Grant DK37922 and a Bridge Grant from the Endocrine Society (to W. L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 5
###begin p 6
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 6
###begin p 7
###xml 50 51 50 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">2</xref>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">195</sup>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 729 730 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
The steroidogenic acute regulatory protein (StAR),2 a nuclear-encoded, mitochondrially targeted protein, is required for adrenal and gonadal steroidogenesis and for male sexual differentiation. StAR moves cholesterol from the outer mitochondrial membrane (OMM) to the inner mitochondrial membrane (IMM) where it is converted to pregnenolone, the precursor of all steroid hormones (Fig. 1A). Lack of StAR causes potentially lethal congenital lipoid adrenal hyperplasia (lipoid CAH) (1). StAR, which acts exclusively on the OMM (2, 3), is expressed in the cytoplasm as a 37-kDa protein, is activated by phosphorylation of Ser195 (4), processed to a 32-kDa intermediate, imported into mitochondria, and cleaved to a 30-kDa protein (5).
###end p 7
###begin p 8
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
Despite intense investigation, the mechanisms of the action of StAR on the OMM remain unknown. Several models have been proposed to explain the mechanism of StAR action (6). Much attention has focused on the peripheral benzodiazepine receptor (PBR), an OMM protein that appears to be involved in steroidogenesis (7), but despite evidence for a functional interaction between PBR and StAR (8), the identity of the OMM proteins with which StAR interacts remains undefined. Here we demonstrate that StAR interacts with voltage-dependent anion channel 1 (VDAC1), and with phosphate carrier protein (PCP) on the OMM to initiate the action of StAR. VDAC1 and PCP are the first OMM proteins definitively shown to interact with StAR.
###end p 8
###begin title 9
EXPERIMENTAL PROCEDURES
###end title 9
###begin p 10
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Reagents and Antibodies</italic>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 415 421 <span type="species:ncbi:9986">Rabbit</span>
Reagents and Antibodies-Antibodies against VDAC1, PCP, glyceraldehyde-3-phosphate dehydrogenase, PBR and COX IV were from Chemicon, Sigma, Calbiochem, and Santa Cruz Biotechnology, respectively. The generation of antiserum against bacterially expressed human StAR, which detects both phospho- and dephospho-StAR, has been described (9). Antiserum specific for phospho-StAR was a gift from Dr. Steven King (10, 11). Rabbit IgG was from Sigma, protein A beads were from Amersham Biosciences, and 2,4-dinitrophenol from Riedel-de Haen (Germany). Dithiocyanate was from Serva/Invitrogen, and 4-sulfophenyl isothiocyanate was from Research Organics. RNase A and Proteinase K were from Roche and GE Health-care, and digitonin was from Calbiochem. Oligonucleotide primers were obtained from Integrated DNA Technology (Ames, IA). All other chemicals were purchased from Sigma, unless otherwise specified.
###end p 10
###begin p 11
###xml 0 95 0 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmid Construction, Cell Culture, Transfection, Mitochondrial Isolation, and Western Blotting</italic>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 751 752 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 838 839 835 836 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 859 860 856 857 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 889 890 883 884 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Plasmid Construction, Cell Culture, Transfection, Mitochondrial Isolation, and Western Blotting-Construction of full-length StAR, R182L StAR, P450scc, and SCC/N-62 StAR cDNA expression vectors was described elsewhere (3). For the StAR-DHFR fusion, residues 1 to 284 of StAR were fused to residues 2 to 224 of DHFR deleting the StAR stop codon and cloned in SP6 vector (3). Cell culture, transfections, and mitochondrial isolation from cultured cells were performed as described (3). In all cases 100 ng/ml trilostane (Steraloids, Los Angeles, CA) was added as an inhibitor of 3beta-hydroxysteroid dehydrogenase. Media were collected from cultures 48 h after transfection and assayed for pregnenolone by radioimmunoassay (MP Biomedicals) as described (1). For Western blot analysis, cells were lysed in 1x SDS sample buffer (0.1% SDS, 10 mm Tris, pH 6.8, 100 mm beta-mercaptoethanol or 10 mm dithiothreitol), resolved by SDS-PAGE, and transferred to polyvinylidene difluoride membranes. Membranes were incubated in 1:100 dilutions of primary antibody, with the exception of anti-StAR antiserum (1:10,000) and anti-phosphoserine StAR antiserum (1:800).
###end p 11
###begin p 12
###xml 184 185 184 185 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 199 200 199 200 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 219 220 219 220 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 230 231 230 231 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 458 459 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 555 556 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 655 656 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 717 718 704 705 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 731 732 718 719 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 741 742 728 729 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 753 754 740 741 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 766 767 753 754 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 776 777 763 764 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 797 798 784 785 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 820 821 807 808 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 829 830 816 817 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 835 836 822 823 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 839 840 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 842 843 829 830 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 849 850 836 837 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 912 913 898 899 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 951 952 937 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 957 965 943 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 998 1000 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1001 1003 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 49 54 <span type="species:ncbi:9940">sheep</span>
For mitochondrial isolation from adrenal tissue, sheep adrenals were isolated immediately after sacrifice. Adrenal tissue was placed in pre-chilled mitochondria isolation buffer (250 mm sucrose, 10 mm HEPES, pH 7.4, 1 mm EGTA, 1 mm phenylmethylsulfonyl fluoride, and 40 mug/ml protease mixture (Roche)). Tissue was then homogenized in an all glass, hand-held Dounce homogenizer with 12 up and down strokes, and cleared of debris by centrifugation at 3,500 x g for 10 min at 4 degreesC. The supernatant (mitochondrial fraction) was centrifuged at 10,000 x g at 4 degreesC, and the resulting mitochondrial pellet was washed twice and re-pelleted at 3,500 x g. For storage, pellets were suspended in import buffer (125 mm sucrose, 2 mm ATP, 2 mm NADH, 50 mm KCl, 0.05 mm ADP, 2 mm dithiothreitol, 5 mm sodium succinate, 2 mm Mg(OAc)2, 2 mm KH2PO4, 10 mm creatine phosphate, 10 mul of creatine kinase (4 mg/ml), 10 mm HEPES pH 7.4), and frozen in liquid N2 for in vitro bioactivity and protein import (12-14).
###end p 12
###begin p 13
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chemical Cross-linking</italic>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 254 256 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 396 397 389 390 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 520 521 507 508 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Chemical Cross-linking-Disuccinimidyl suberate (Pierce) was dissolved in Me2SO and sequentially diluted with import buffer just before cross-linking. Freshly isolated mitochondria from adrenal tissues (100 mug) were incubated with cell-free synthesized [35S]StAR for 15 min at 20 degreesC. Disuccinimidyl suberate was then added directly to the reaction mixture, to a final concentration of 0.1 mm, and incubated at 4 degreesC and at room temperature for 5 min to 2 h. The reaction was terminated by the addition of 10 mm Tris, pH 9.5, and 1x SDS sample buffer. Samples were then boiled for 15 min and analyzed by 12.5% SDS-PAGE. The darker radioactive band was excised and analyzed by mass spectrometry. Equivalent results were obtained with three other homobifunctional cross-linking agents: disuccinimidyl glutarate, bis(sulfosuccinimidyl)suberate, and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride.
###end p 13
###begin p 14
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mass Spectrometry</italic>
Mass Spectrometry-Excised bands were processed for mass spectrometry in an automated in-gel tryptic digestion ("Waters MassPREP Station" system, Waters, MA). Following electrophoresis, blue native-PAGE gels were fixed in 10% acetic acid, washed with water for 24 h, dried, and exposed to x-ray film. The radioactive gel bands were excised, reduced, alkylated with iodoacetamide, and digested with trypsin (Promega Sequencing grade modified). The resulting peptides were analyzed via liquid chromatography-mass spectrometry (MS)/MS (Waters) coupled with a Q-ToF-2 mass spectrometer (Micromass, UK/Waters, MA). Proteins were identified from MS/MS spectra by searching the NCBI non-redundant data base using Mas-cot MS/MS Ion Search (Matrix Science, UK). Search parameters included carbamidomethylation of cysteine, possible oxidation of methionine, and one missed cleavage per peptide. In our experiment, an individual ion score greater than 39 (-10 log(P) at 95% confidence) indicated extensive homology; mass spectrometry scores ranged from 60 to 438.
###end p 14
###begin p 15
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunoprecipitation</italic>
###xml 160 161 154 155 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 221 222 215 216 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Immunoprecipitation-Total digitonin extracts or fractions from sucrose density gradients were immunoprecipitated overnight at 4 degreesC with antibodies in 25 mm Tris-HCl, pH 7.5, 1% Triton X-100, 0.5% Nonidet P-40, 200 mm NaCl, 0.5% sodium deoxycholate, and protease inhibitor mixture. The protein-IgG complex was harvested with protein A-Sepharose CL-4B, eluted by boiling for 15 min in 1x SDS-sample buffer, and analyzed by SDS-PAGE.
###end p 15
###begin p 16
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K&#246;enig's Polyanion Treatment</italic>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 142 143 142 143 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 178 179 178 179 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 498 499 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 526 528 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 1165 1167 1157 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1228 1230 1220 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
Koenig's Polyanion Treatment-Koenig's polyanion (15) (KPA, a kind gift from Dr. Marco Colombini, University of Maryland) was dissolved in 10 mm NaOH, adjusted to pH 7.0 with 50 mm NaOAc, pH 4.0, and stored at 4 degreesC. Prior to use, the solution was equilibrated with import buffer or media as required. Two different concentrations of KPA (30 and 90 mg/ml) were incubated with COS-1 cells 24 h prior to co-transfection with StAR and the F2 fusion of the cholesterol side chain cleavage system (H2N-P450scc-AdRed-Adx-COOH) (16). Pregnenolone concentrations in the media were then determined, and cell lysates were analyzed for StAR processing by Western blot. Western blot signals were developed by West-Pico chemilumiscent reagent (Pierce). For direct measurement of activity, mitochondria (2 mug of protein) were incubated with the above mentioned concentration of KPA for 2 h and then incubated with biosynthetic StAR. For transient VDAC channel blockage, mitochondria were incubated with 30 mg/ml KPA, re-isolated, and resuspended in import buffer. For analysis of StAR mitochondrial import, 100 mug of mitochondria were incubated with cell-free synthesized [35S]StAR in the presence of 10 to 90 mg/ml KPA. Mitochondrial [35S]StAR was then analyzed by SDS-PAGE.
###end p 16
###begin p 17
###xml 0 34 0 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Blocking Phosphate Carrier Protein</italic>
###xml 120 121 120 121 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 227 228 227 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 289 290 289 290 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 378 380 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 429 430 423 424 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Blocking Phosphate Carrier Protein-Mitochondria (20 mg of protein) isolated from adrenal tissues were incubated with 2 mm phenylisothiocyanate (PITC) or sulfo-PITC for 10 min on ice, and reactions were terminated by adding 10 mm dithiocyanate. Mitochondria were then washed twice with 10 mm dithiocyanate, resuspended in import buffer, and incubated with cell-free synthesized [35S]StAR for 2 h at 26 degreesC. In some cases, 1 mm ATP was included in the reaction mixture. Mitochondrial import was examined by analyzing a 20-mul aliquot by SDS-PAGE.
###end p 17
###begin p 18
###xml 0 51 0 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Antibody Shift Native-PAGE and Blocking Experiments</italic>
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 491 493 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 155 160 <span type="species:ncbi:9940">sheep</span>
Antibody Shift Native-PAGE and Blocking Experiments-Cell-free synthesized [35S]StAR was imported into mitochondria (20 mug of protein) from MA-10 cells or sheep adrenals for 10 min. Mitochondria were then resuspended in 100 mul of mitochondria isolation buffer and incubated with antiserum (suspended in 40 mul of import buffer) for 30 min on ice. Reisolated mitochondria were washed with import buffer two times and extracted in digitonin buffer (1% digitonin) and analyzed by native-PAGE (17). For antibody blocking experiments, mitochondria were incubated with IgG or VDAC1 antiserum to VDAC1 prior to import.
###end p 18
###begin p 19
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bioactivity in Isolated Mitochondria</italic>
###xml 207 208 205 206 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 222 223 220 221 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 232 233 230 231 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 238 239 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 245 246 243 244 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 250 251 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 253 254 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 260 261 258 259 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 278 279 276 277 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 292 293 290 291 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 437 438 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 510 511 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
Bioactivity in Isolated Mitochondria-Mitochondria (2 mugof protein) from control or VDAC1 knockdown MA-10 cells or from adrenal tissues were resuspended in a final volume of 100 mul of bioassay buffer (125 mm sucrose, 80 mm KCl, 5 mm MgCl2, 10 mm NaH2PO4, 10 mm isocitrate, 25 mm HEPES, 0.1 mm ATP, and 10 mg/ml cholesterol, pH 7.4), incubated with full-length, cell-free synthesized or biosynthetic StAR under the conditions described (3). Supernatants were then assayed for pregnenolone by radioimmunoassay (1).
###end p 19
###begin p 20
###xml 0 29 0 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Generation of VDAC1 Antiserum</italic>
###xml 1269 1272 1269 1272 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m l</sc>
###xml 1596 1597 1596 1597 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1624 1625 1624 1625 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1705 1706 1704 1705 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 243 250 <span type="species:ncbi:9986">rabbits</span>
###xml 544 551 <span type="species:ncbi:9986">Rabbits</span>
Generation of VDAC1 Antiserum-Antiserum specific to VDAC1 was custom raised by Alpha Diagnostic International (San Antonio, TX) against a keyhole limpet hemocyanin-conjugated synthetic peptide comprising amino acids 151-165. New Zealand White rabbits received an initial injection of keyhole limpet hemocyanin-conjugated peptide and 14 days later received an additional injection, followed by a booster injection on every 7th day to day 63. At this time, the antiserum titer exceeded 1:1000, as determined by enzyme-linked immunosorbent assay. Rabbits were then sacrificed and all serum was collected. The affinity purification of VDAC1 antibody was carried out after cross-linking a peptide corresponding to residues 151-165 of VDAC1 with a SulfoLink column following the manufacturer's instructions (Pierce, Sulfolink Immobilization kit). The SulfoLink column was equilibrated at room temperature with coupling buffer. Peptide-(151-165) (1 mg) was dissolved in coupling buffer, then coupled with the resin by mixing 15 min at room temperature on a rocker followed by an additional 30 min of incubation without rocking. The unbound peptide was removed by centrifugation and three washes with coupling buffer, then nonspecific sites of the column were blocked with 50 mm l-cysteine. Before purification, the column was equilibrated with phosphate-buffered saline. The antiserum was purified in batches. Antiserum (2 ml) was incubated with the column on a rocker for 30 min, the unbound antibodies were removed, and the column was washed three times with phosphate-buffered saline containing 100 mm NaCl and eluted with 100 mm glycine at pH 3.0, which was immediately titrated by addition of 65 mul of 1.0 m Tris, pH 9.5. The purified antiserum was dialyzed with phosphate-buffered saline.
###end p 20
###begin p 21
###xml 0 52 0 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDAC1 Knockdown and Development of Stable Cell Lines</italic>
###xml 1135 1151 1131 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 837 840 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1135 1151 <span type="species:ncbi:562">Escherichia coli</span>
VDAC1 Knockdown and Development of Stable Cell Lines-siRNA (CCCUAAAACCAGGUAUCAA) for VDAC1 was obtained from Ambion (Austin, TX). COS-1 and MA-10 cells were transfected with 30 and 60 pmol of VDAC1 siRNA, respectively, using Oligofectamine (Invitrogen), according to the manufacturer's protocol. Non-targeting siRNA (Ambion) served as a control in all experiments. A combination of two non-targeting scrambled siRNAs (Ambion) was also included as control in all experiments. A subset of cells was co-transfected with an expression vector for VDAC1 cDNA in which two nucleotides in the siRNA target region were mutated. VDAC1 was mutated without altering the amino acid sequence as follows: CCCTAAAA(C-->T)CA(G-->A)GTATCAA. The pSilencer siRNA expression plasmid was constructed by ligating the 55-mer siRNA template into a pSilencer 4.1 CMV expression vector (Ambion, TX). Complementary 55-mer siRNA oligonucleotides (5-GATCCCCCTAAAACCAGGTATCAATTCAAGAGATTGATACCTGGTTTTAGGGAGA-3' and 3'-GGGGATTTTGGTCCATAGTTAAGTTCTCTAACTATGGACCAAAATCCCTCTTCGA-5') were annealed, ligated into pSilencer neovector (Ambion), and transformed into competent Escherichia coli to screen for positive hairpin siRNA inserts. The accuracy of the knockdown was determined by Western blotting. For generation of stable cell lines, COS-1 and MA-10 cells were independently transfected with the purified plasmid using Lipofectamine (Invitrogen). Forty-eight hours after transfection, single clones were generated by limiting dilution into a selection medium containing 600 mug/ml G418 (Geneticin, GE Healthcare). Individual clones were then transferred to 24-well plates (Greiner, Germany) for propagation and then later transferred to 6-cm plates for transfection with StAR and F2. Individual clones were examined for VDAC1 expression by Western blotting. For knockdown of PCP, 20 pmol of PCP siRNA (GGUUAUGCCAACACUUUGATT) was transfected, as described for VDAC1 siRNA. Expression of PCP was examined 48 h after transfection. Western blotting was performed with 12.5 mugof protein and PCP-specific antibody (1:200) dilution. Signals were developed with West-Pico chemilumiscent reagent (Pierce).
###end p 21
###begin p 22
###xml 0 87 0 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Vitro Transcription/Translation, Mitochondrial Import, and Protein Complex Isolation</italic>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 131 132 131 132 <sc xmlns:xlink="http://www.w3.org/1999/xlink">n</sc>
###xml 228 230 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 465 466 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 706 708 687 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 770 771 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 1089 1090 1056 1057 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1114 1115 1081 1082 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1126 1127 1093 1094 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1157 1158 1124 1125 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1209 1211 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 1320 1321 1287 1288 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1344 1345 1311 1312 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1683 1684 1642 1643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 134 140 <span type="species:ncbi:9986">rabbit</span>
###xml 569 574 <span type="species:ncbi:9940">sheep</span>
In Vitro Transcription/Translation, Mitochondrial Import, and Protein Complex Isolation-In vitro translation was performed in the TnT rabbit reticulocyte system (Promega). Translation of cDNA was carried out in the presence of [35S]methionine or unlabeled methionine with SP6 polymerase at 30 degreesC for 90 min, according to the manufacturer's instructions. Ribosomes and ribosome-bound nascent polypeptide chains were removed by ultracentrifugation at 148,000 x g for 20 min at 4 degreesC. Translated proteins were allowed to undergo brief import by incubation with sheep adrenal mitochondria (100 mug of protein) at 26 degreesC for 10 min. For import and blocking experiments, mitochondrial import of [35S]StAR (2 mul) was allowed to proceed for 2 h at 26 degreesC (3). Partial proteolysis was carried out with 10 mug/ml proteinase K for 15 min at 4 degreesC. Reactions were terminated with phenylmethylsulfonyl fluoride and heat inactivation. For analysis of the assembled proteins in the complex, mitochondria were re-isolated and lysed in digitonin buffer ((1% (w/v) digitonin, 20 mm Tris-HCl, pH 7.4, 0.1 mm EDTA, 50 mm NaCl, 10% (w/v) glycerol, 1 mm phenylmethylsulfonyl fluoride) for 15 min on ice (18). The digitonin lysate was combined with native-PAGE sample buffer (5% Coomassie Brilliant Blue G-250, 100 mm BisTris, pH 7.0, 500 mm 6-aminocaproic acid) and subjected to 3-16% gradient native-PAGE at 100 V overnight at 4 degreesC. Protein complexes were further fractionated by applying 100 mul of digitonin lysate to a 30-10% sucrose density step gradient, with a 200-mul 66% sucrose cushion at the bottom (final volume = 2.0 ml). Following centrifugation at 55,000 x g in a Beckman TLA55 rotor for 4 h, the sample was immediately equally aliquoted and loaded onto gradient, native-PAGE (20 mul) or SDS-PAGE gels (20 mul). Radiolabeled proteins were detected by digital autoradiography or on a phosphorimager.
###end p 22
###begin p 23
###xml 0 32 0 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pulse-Chase Labeling Experiments</italic>
###xml 207 209 207 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 325 326 325 326 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 445 446 445 446 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 506 507 506 507 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Pulse-Chase Labeling Experiments-COS-1 cells transfected with StAR or N-62 StAR were incubated with methionine-free Dulbecco's modified Eagle's medium without serum for 30 min, then labeled with 0.1 mCi of [35S]methionine for 30 min. After labeling, the medium was changed to Dulbecco's modified Eagle's medium containing 4 mm methionine and chased for the times indicated. Cells were than scraped into immunoprecipitation buffer containing 25 mm Tris-HCl, pH 7.5, 1% Triton X-100, 0.5% Nonidet P-40, 200 mm NaCl, 0.5% sodium deoxycholate, and protease inhibitor mixture. The lysed cells were aliquoted in smaller fractions and immunoprecipitated with the indicated antibodies, as described above.
###end p 23
###begin p 24
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 73 9 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the interaction of VDAC1 with StAR on the OMM.</bold>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR</italic>
###xml 177 179 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 323 324 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 342 351 336 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 397 398 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 488 489 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 606 607 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 791 794 785 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neg</italic>
###xml 872 873 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 895 896 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1006 1007 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1162 1163 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1474 1484 1468 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels E&#8211;H</italic>
###xml 9 1563 9 1555 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><bold>Identification of the interaction of VDAC1 with StAR on the OMM.</bold><italic>A</italic>, simplified scheme of steroid hormone biosynthesis. <italic>B</italic>, disuccinimidyl suberate cross-linking (<italic>CR</italic>) of [<sup>35</sup>S]StAR synthesized in a cell-free transcription/translation system to OMM proteins on fresh mitochondria at 4 &#176;C and at room temperature (<italic>R</italic>). A 75-kDa band (<italic>arrowhead</italic>) appeared with increased cross-linking time. <italic>C</italic>, mass spectrum (MS/MS) of the predominant VDAC1 peptide associated with the 75-kDa band. <italic>D</italic>, immunoprecipitation of cross-linked proteins with antisera to StAR, VDAC1, VDAC2, Tom40, and StAR preimmune serum. <italic>E</italic>, effect of VDAC1 knockdown on pregnenolone synthesis in COS-1 cells transfected with the indicated plasmids. There was no decrease in pregnenolone with nonspecific mixtures of siRNA (<italic>Neg</italic>). VDAC1 knockdown did not alter pregnenolone levels in cells treated with 22(<italic>R</italic>)-hydroxycholesterol. <italic>F</italic>, effect on steroidogenesis of blocking VDAC1 with KPA in COS-1 cells transfected with the indicated vectors. <italic>G</italic>, measurement of accumulated pregnenolone synthesis in COS-1 cells co-transfected with StAR/F2 in the presence of KPA, atractyloside, and bongkrekic acid. <italic>H</italic>, transient blocking of VDAC1 stops pregnenolone synthesis in MA-10 cell mitochondria incubated with biosynthetic StAR in the presence of KPA. Mitochondria previously treated with KPA were reisolated and reincubated with unlabeled cell-free synthesized StAR, then pregnenolone synthesis was determined. Data in <italic>panels E&#8211;H</italic> are mean &#177; S.E. of three separate experiments, each performed in triplicate.</p>
###xml 9 1563 9 1555 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25"><bold>Identification of the interaction of VDAC1 with StAR on the OMM.</bold><italic>A</italic>, simplified scheme of steroid hormone biosynthesis. <italic>B</italic>, disuccinimidyl suberate cross-linking (<italic>CR</italic>) of [<sup>35</sup>S]StAR synthesized in a cell-free transcription/translation system to OMM proteins on fresh mitochondria at 4 &#176;C and at room temperature (<italic>R</italic>). A 75-kDa band (<italic>arrowhead</italic>) appeared with increased cross-linking time. <italic>C</italic>, mass spectrum (MS/MS) of the predominant VDAC1 peptide associated with the 75-kDa band. <italic>D</italic>, immunoprecipitation of cross-linked proteins with antisera to StAR, VDAC1, VDAC2, Tom40, and StAR preimmune serum. <italic>E</italic>, effect of VDAC1 knockdown on pregnenolone synthesis in COS-1 cells transfected with the indicated plasmids. There was no decrease in pregnenolone with nonspecific mixtures of siRNA (<italic>Neg</italic>). VDAC1 knockdown did not alter pregnenolone levels in cells treated with 22(<italic>R</italic>)-hydroxycholesterol. <italic>F</italic>, effect on steroidogenesis of blocking VDAC1 with KPA in COS-1 cells transfected with the indicated vectors. <italic>G</italic>, measurement of accumulated pregnenolone synthesis in COS-1 cells co-transfected with StAR/F2 in the presence of KPA, atractyloside, and bongkrekic acid. <italic>H</italic>, transient blocking of VDAC1 stops pregnenolone synthesis in MA-10 cell mitochondria incubated with biosynthetic StAR in the presence of KPA. Mitochondria previously treated with KPA were reisolated and reincubated with unlabeled cell-free synthesized StAR, then pregnenolone synthesis was determined. Data in <italic>panels E&#8211;H</italic> are mean &#177; S.E. of three separate experiments, each performed in triplicate.</p></caption>
###xml 1563 1563 1555 1555 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0170832510001"/>
###xml 0 1563 0 1555 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="25"><bold>Identification of the interaction of VDAC1 with StAR on the OMM.</bold><italic>A</italic>, simplified scheme of steroid hormone biosynthesis. <italic>B</italic>, disuccinimidyl suberate cross-linking (<italic>CR</italic>) of [<sup>35</sup>S]StAR synthesized in a cell-free transcription/translation system to OMM proteins on fresh mitochondria at 4 &#176;C and at room temperature (<italic>R</italic>). A 75-kDa band (<italic>arrowhead</italic>) appeared with increased cross-linking time. <italic>C</italic>, mass spectrum (MS/MS) of the predominant VDAC1 peptide associated with the 75-kDa band. <italic>D</italic>, immunoprecipitation of cross-linked proteins with antisera to StAR, VDAC1, VDAC2, Tom40, and StAR preimmune serum. <italic>E</italic>, effect of VDAC1 knockdown on pregnenolone synthesis in COS-1 cells transfected with the indicated plasmids. There was no decrease in pregnenolone with nonspecific mixtures of siRNA (<italic>Neg</italic>). VDAC1 knockdown did not alter pregnenolone levels in cells treated with 22(<italic>R</italic>)-hydroxycholesterol. <italic>F</italic>, effect on steroidogenesis of blocking VDAC1 with KPA in COS-1 cells transfected with the indicated vectors. <italic>G</italic>, measurement of accumulated pregnenolone synthesis in COS-1 cells co-transfected with StAR/F2 in the presence of KPA, atractyloside, and bongkrekic acid. <italic>H</italic>, transient blocking of VDAC1 stops pregnenolone synthesis in MA-10 cell mitochondria incubated with biosynthetic StAR in the presence of KPA. Mitochondria previously treated with KPA were reisolated and reincubated with unlabeled cell-free synthesized StAR, then pregnenolone synthesis was determined. Data in <italic>panels E&#8211;H</italic> are mean &#177; S.E. of three separate experiments, each performed in triplicate.</p></caption><graphic xlink:href="zbc0170832510001"/></fig>
FIGURE 1.Identification of the interaction of VDAC1 with StAR on the OMM.A, simplified scheme of steroid hormone biosynthesis. B, disuccinimidyl suberate cross-linking (CR) of [35S]StAR synthesized in a cell-free transcription/translation system to OMM proteins on fresh mitochondria at 4 degreesC and at room temperature (R). A 75-kDa band (arrowhead) appeared with increased cross-linking time. C, mass spectrum (MS/MS) of the predominant VDAC1 peptide associated with the 75-kDa band. D, immunoprecipitation of cross-linked proteins with antisera to StAR, VDAC1, VDAC2, Tom40, and StAR preimmune serum. E, effect of VDAC1 knockdown on pregnenolone synthesis in COS-1 cells transfected with the indicated plasmids. There was no decrease in pregnenolone with nonspecific mixtures of siRNA (Neg). VDAC1 knockdown did not alter pregnenolone levels in cells treated with 22(R)-hydroxycholesterol. F, effect on steroidogenesis of blocking VDAC1 with KPA in COS-1 cells transfected with the indicated vectors. G, measurement of accumulated pregnenolone synthesis in COS-1 cells co-transfected with StAR/F2 in the presence of KPA, atractyloside, and bongkrekic acid. H, transient blocking of VDAC1 stops pregnenolone synthesis in MA-10 cell mitochondria incubated with biosynthetic StAR in the presence of KPA. Mitochondria previously treated with KPA were reisolated and reincubated with unlabeled cell-free synthesized StAR, then pregnenolone synthesis was determined. Data in panels E-H are mean +/- S.E. of three separate experiments, each performed in triplicate.
###end p 24
###begin p 25
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the interaction of VDAC1 with StAR on the OMM.</bold>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 160 162 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CR</italic>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 314 315 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 333 342 327 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrowhead</italic>
###xml 388 389 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 479 480 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 597 598 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 782 785 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neg</italic>
###xml 863 864 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 886 887 880 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 997 998 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1153 1154 1147 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1465 1475 1459 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels E&#8211;H</italic>
Identification of the interaction of VDAC1 with StAR on the OMM.A, simplified scheme of steroid hormone biosynthesis. B, disuccinimidyl suberate cross-linking (CR) of [35S]StAR synthesized in a cell-free transcription/translation system to OMM proteins on fresh mitochondria at 4 degreesC and at room temperature (R). A 75-kDa band (arrowhead) appeared with increased cross-linking time. C, mass spectrum (MS/MS) of the predominant VDAC1 peptide associated with the 75-kDa band. D, immunoprecipitation of cross-linked proteins with antisera to StAR, VDAC1, VDAC2, Tom40, and StAR preimmune serum. E, effect of VDAC1 knockdown on pregnenolone synthesis in COS-1 cells transfected with the indicated plasmids. There was no decrease in pregnenolone with nonspecific mixtures of siRNA (Neg). VDAC1 knockdown did not alter pregnenolone levels in cells treated with 22(R)-hydroxycholesterol. F, effect on steroidogenesis of blocking VDAC1 with KPA in COS-1 cells transfected with the indicated vectors. G, measurement of accumulated pregnenolone synthesis in COS-1 cells co-transfected with StAR/F2 in the presence of KPA, atractyloside, and bongkrekic acid. H, transient blocking of VDAC1 stops pregnenolone synthesis in MA-10 cell mitochondria incubated with biosynthetic StAR in the presence of KPA. Mitochondria previously treated with KPA were reisolated and reincubated with unlabeled cell-free synthesized StAR, then pregnenolone synthesis was determined. Data in panels E-H are mean +/- S.E. of three separate experiments, each performed in triplicate.
###end p 25
###begin p 26
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Measurement of ATP</italic>
###xml 98 99 98 99 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 124 125 123 124 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Measurement of ATP-COS-1 or MA-10 cells were serum starved for 24 h and then stimulated with 100 mm 2-deoxyglucose and 20 mum rotenone. Media were collected for radioimmunoassay, and cell lysates were analyzed for StAR and phosphoserine-StAR by Western blot. Cellular ATP content was determined using a kit according to the manufacturer's instructions (ENLITEN ATP Assay system, Promega).
###end p 26
###begin title 27
RESULTS
###end title 27
###begin p 28
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Identification of VDAC1</italic>
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 357 364 357 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 921 928 921 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 966 967 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 960 967 960 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1367 1368 1367 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1361 1368 1361 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 242 247 <span type="species:ncbi:9940">sheep</span>
Identification of VDAC1-StAR activity is maximal when it is affixed to the OMM (3), suggesting that StAR interacts with OMM proteins. [35S]StAR synthesized in a cell-free system was chemically cross-linked to OMM proteins on freshly prepared sheep adrenal mitochondria using disuccinimidyl suberate. This consistently generated a 75-kDa consistent complex (Fig. 1B). Other homobifunctional cross-linkers cross-linked a band of similar size (not shown). This 75-kDa band was specific as observed on titration with different concentrations of cross-linkers (data not shown). Mass spectrometry showed that the bands at about 50 and 60 kDa did not contain StAR, and that the dark band at 50 kDa was globulin. Considering the specificity of the cross-linking products, the 75-kDa band was excised, digested with trypsin, and analyzed by mass spectrometry. In 12 experiments, 5 peptides corresponding to VDAC1 were identified (Table 1); two of these, LTFDSSFSPNTGK (Fig. 1C) and VTQSNFAVGYK (not shown), were seen in 10 of 12 experiments. A model structure of VDAC1 (19) indicates these two peptides are exposed to cytoplasm. Immunoprecipitation of cross-linked proteins with StAR and VDAC1 antibodies also yielded a 75-kDa band, whereas immunoprecipitation with antisera to Tom 40, PBR, or VDAC2 did not, demonstrating the specificity of the StAR-VDAC1 interaction (Fig. 1D). The relatively minor band above the major 75-kDa band did not yield enough protein for mass spectrometric analysis, even when multiple gel fractions were pooled together.
###end p 28
###begin p 29
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 7 41 7 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VDAC1 peptides identified by MS/MS</bold>
###xml 7 41 7 41 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30"><bold>VDAC1 peptides identified by MS/MS</bold></p>
###xml 7 41 7 41 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30"><bold>VDAC1 peptides identified by MS/MS</bold></p></caption>
###xml 41 49 41 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Position</bold>
###xml 41 49 41 49 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th>
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 49 51 49 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>M</italic><sub>r</sub></bold>
###xml 49 51 49 51 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>M</italic><sub>r</sub></bold></th>
###xml 51 59 51 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence</bold>
###xml 51 59 51 59 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th>
###xml 41 59 41 59 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>M</italic><sub>r</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr>
###xml 41 59 41 59 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>M</italic><sub>r</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr></thead>
###xml 59 66 59 66 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 53-60 </td>
###xml 66 74 66 74 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 833.44 </td>
###xml 74 84 74 84 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> VTGSLETK </td>
###xml 59 84 59 84 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 53-60 </td><td colspan="1" rowspan="1" align="center" valign="top"> 833.44 </td><td colspan="1" rowspan="1" align="left" valign="top"> VTGSLETK </td></tr>
###xml 84 93 84 93 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 256-265 </td>
###xml 93 102 93 102 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1029.58 </td>
###xml 102 114 102 114 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> LTLSALLDGK </td>
###xml 84 114 84 114 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 256-265 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1029.58 </td><td colspan="1" rowspan="1" align="left" valign="top"> LTLSALLDGK </td></tr>
###xml 114 123 114 123 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 163-173 </td>
###xml 123 132 123 132 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1212.59 </td>
###xml 132 143 132 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VTQSNFAVGYK</bold>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 143 144 143 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><sup><italic>a</italic></sup></bold>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref>
###xml 132 144 132 144 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><bold>VTQSNFAVGYK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td>
###xml 114 144 114 144 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 163-173 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1212.59 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>VTQSNFAVGYK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr>
###xml 144 152 144 152 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 96-108 </td>
###xml 152 161 152 161 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1399.68 </td>
###xml 161 174 161 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LTFDSSFSPNTGK</bold>
###xml 174 175 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 174 175 174 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 174 175 174 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><sup><italic>a</italic></sup></bold>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref>
###xml 161 175 161 175 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><bold>LTFDSSFSPNTGK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td>
###xml 144 175 144 175 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 96-108 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1399.68 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>LTFDSSFSPNTGK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr>
###xml 175 182 175 182 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 34-52 </td>
###xml 182 191 182 191 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1958.82 </td>
###xml 191 212 191 212 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> SENGLEFTSSGSANTETTK </td>
###xml 175 212 175 212 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 34-52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1958.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> SENGLEFTSSGSANTETTK </td></tr>
###xml 59 212 59 212 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"> 53-60 </td><td colspan="1" rowspan="1" align="center" valign="top"> 833.44 </td><td colspan="1" rowspan="1" align="left" valign="top"> VTGSLETK </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 256-265 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1029.58 </td><td colspan="1" rowspan="1" align="left" valign="top"> LTLSALLDGK </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 163-173 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1212.59 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>VTQSNFAVGYK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 96-108 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1399.68 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>LTFDSSFSPNTGK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 34-52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1958.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> SENGLEFTSSGSANTETTK </td></tr></tbody>
###xml 41 212 41 212 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>M</italic><sub>r</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> 53-60 </td><td colspan="1" rowspan="1" align="center" valign="top"> 833.44 </td><td colspan="1" rowspan="1" align="left" valign="top"> VTGSLETK </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 256-265 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1029.58 </td><td colspan="1" rowspan="1" align="left" valign="top"> LTLSALLDGK </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 163-173 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1212.59 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>VTQSNFAVGYK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 96-108 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1399.68 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>LTFDSSFSPNTGK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 34-52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1958.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> SENGLEFTSSGSANTETTK </td></tr></tbody></table>
###xml 212 213 212 213 <label xmlns:xlink="http://www.w3.org/1999/xlink">a</label>
###xml 213 245 213 245 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">Frequently associated with StAR.</p>
###xml 212 245 212 245 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn1"><label>a</label><p textid="31">Frequently associated with StAR.</p></fn>
###xml 212 245 212 245 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn id="tblfn1"><label>a</label><p textid="31">Frequently associated with StAR.</p></fn></table-wrap-foot>
###xml 0 245 0 245 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="30"><bold>VDAC1 peptides identified by MS/MS</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>M</italic><sub>r</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> 53-60 </td><td colspan="1" rowspan="1" align="center" valign="top"> 833.44 </td><td colspan="1" rowspan="1" align="left" valign="top"> VTGSLETK </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 256-265 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1029.58 </td><td colspan="1" rowspan="1" align="left" valign="top"> LTLSALLDGK </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 163-173 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1212.59 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>VTQSNFAVGYK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 96-108 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1399.68 </td><td colspan="1" rowspan="1" align="left" valign="top"><bold>LTFDSSFSPNTGK</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 34-52 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1958.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> SENGLEFTSSGSANTETTK </td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>a</label><p textid="31">Frequently associated with StAR.</p></fn></table-wrap-foot></table-wrap>
TABLE 1VDAC1 peptides identified by MS/MSPositionMrSequence 53-60  833.44  VTGSLETK  256-265  1029.58  LTLSALLDGK  163-173  1212.59 VTQSNFAVGYKa 96-108  1399.68 LTFDSSFSPNTGKa 34-52  1958.82  SENGLEFTSSGSANTETTK aFrequently associated with StAR.
###end p 29
###begin p 30
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VDAC1 peptides identified by MS/MS</bold>
VDAC1 peptides identified by MS/MS
###end p 30
###begin p 31
Frequently associated with StAR.
###end p 31
###begin p 32
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Role of VDAC1 in StAR Activity</italic>
###xml 260 261 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 445 446 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 439 446 439 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>E</italic></xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 789 796 789 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>F</italic></xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1184 1185 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1178 1185 1178 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>G</italic></xref>
###xml 1205 1206 1205 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1494 1495 1494 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1488 1495 1488 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>H</italic></xref>
Role of VDAC1 in StAR Activity-To understand the significance of StAR-VDAC1 interactions, we used siRNA to knockdown VDAC1 in COS-1 cells co-transfected with expression vectors for StAR and the F2 fusion protein of the cholesterol side chain cleavage system (H2N-P450scc-Ad-Red-Adx-COOH) (16), or for F2 and StAR lacking 62 N-terminal residues (N-62 StAR), which is as active as full-length StAR but is not imported into mitochondria (3) (Fig. 1E). Knockdown of VDAC1 inhibited pregnenolone synthesis, but synthesis could be restored by co-transfecting a VDAC-1 expression plasmid in which two nucleotides within the siRNA region were mutated. As an alternative to siRNA-mediated VDAC1 knockdown, cells were treated with KPA, a selective inhibitor of VDAC1 (20), reducing activity by 74% (Fig. 1F). VDAC1 is associated with adenine nucleotide transporter (ANT) on the IMM (21). Bongkrekic acid blocks the transfer of phosphate across the IMM and atractyloside inhibits transport of phosphate from the OMM to IMM by blocking ANT (22). Blocking of ANT with bongkrekic acid or atractyloside in COS-1 cells cotransfected with StAR and F2 showed no effect on pregnenolone synthesis (Fig. 1G). Water-soluble 22(R)-OH cholesterol, which bypasses the action of StAR, retained equivalent activity in all conditions, indicating that absence of VDAC1 did not affect P450scc. Similarly, when StAR was incubated with steroidogenic mitochondria, no pregnenolone was synthesized in the presence of KPA (Fig. 1H), but ANT blockers had no effect (not shown). Re-isolation of the KPA-treated mitochondria and reincubation with StAR restored pregnenolone synthesis, showing that temporary blocking of VDAC1 prevented cholesterol delivery. These results provide evidence that StAR-VDAC1 interactions are required for mitochondrial cholesterol import.
###end p 32
###begin p 33
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 239 246 239 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 458 465 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 615 622 615 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 830 831 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 824 831 824 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 1029 1030 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1023 1030 1023 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
Western blotting showed that VDAC1 knockdown in StAR-transfected cells reduced expression of the 37-kDa precursor, 32-kDa intermediate, and 30-kDa mature forms of StAR, respectively, and that there is no expression of phosphorylated StAR (Fig. 2A). Western blotting of COS-1 cells co-transfected with F2, N-62 StAR, and a VDAC1 knockdown vector showed reduced expression of phospho-StAR, but the expression of nonphosphorylated N-62 StAR remained unaltered (Fig. 2B). This effect is specific to StAR, as glyceraldehyde-3-phosphate dehydrogenase and mitochondrial COX-IV remained unchanged in VDAC1 knockdown cells (Fig. 2A). Surprisingly, blocking VDAC1 after preincubating the cells with two different concentrations of KPA suppressed the processing of phosphorylated 32-kDa StAR to 30-kDa StAR in transfected COS-1 cells (Fig. 2C). Pulse-chase experiments of StAR-transfected COS-1 cells showed no processing of 32 to 30-kDa phospho-StAR in the presence of KPA, but processing of non-phosphorylated StAR was not altered (Fig. 2D). These results suggest that processing from 32 to 30 kDa phospho-StAR requires VDAC1.
###end p 33
###begin p 34
###xml 98 100 98 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 192 199 192 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 773 774 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 767 774 767 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>F</italic></xref>
###xml 845 846 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 839 846 839 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>G</italic></xref>
###xml 923 924 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 917 924 917 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>F</italic></xref>
###xml 992 993 992 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 986 993 986 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>G</italic></xref>
###xml 995 1007 995 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panel</italic>
###xml 1126 1127 1126 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1120 1127 1120 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>G</italic></xref>
###xml 1129 1138 1129 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top panel</italic>
We next addressed how VDAC1 influences StAR phosphorylation and activity. The import kinetics of [35S]StAR with mitochondria from normal or VDAC-1 knockdown COS-1 cells were almost identical (Fig. 2E). Cell-free synthesized StAR is phosphorylated (23) and VDAC1 is necessary for the processing of StAR, thus the import of [35S]StAR remained unchanged in VDAC1 knockdown cells. In the absence of VDAC1, StAR might be misfolded, rendering it susceptible to proteolytic degradation. To test this hypothesis, VDAC1 knockdown cells were incubated with MG132, lactacystin, and E64; MG132 and lactacystin are proteasomal inhibitors (24), whereas E64 is an inhibitor of cysteine proteases but not proteasomes (25). Pregnenolone synthesis was marginally increased with MG132 (Fig. 2F), but lactacystin had no effect on StAR activity or expression (Fig. 2G). Surprisingly, pregnenolone synthesis was restored to 100% with E64 (Fig. 2F), accompanied by restoration of 37- and 32-kDa phospho-StAR (Fig. 2G, bottom panel). Increased levels of the non-phosphorylated 37- and 32-kDa StAR were seen in cells treated with MG132 and E64 (Fig. 2G, top panel), suggesting that these proteasome inhibitors protected non-phosphorylated StAR. These data suggest that misfolded StAR cannot remain in the cytoplasm and is degraded by cysteine proteases.
###end p 34
###begin p 35
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Identification of PCP</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 625 627 625 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 889 890 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 883 890 883 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 998 999 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 992 999 992 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1065 1066 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1059 1066 1059 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 1277 1278 1277 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1271 1278 1271 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1468 1470 1468 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1540 1547 1540 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1599 1600 1599 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1593 1600 1593 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 1789 1790 1789 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1783 1790 1783 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1865 1867 1865 1867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1898 1899 1898 1899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1892 1899 1892 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 2177 2178 2177 2178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 2171 2178 2171 2178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>E</italic></xref>
###xml 92 97 <span type="species:ncbi:4932">Yeast</span>
###xml 586 591 <span type="species:ncbi:9940">sheep</span>
Identification of PCP-It is not clear how StAR is dephosphorylated in the absence of VDAC1. Yeast mitochondria have a 32-kDa PCP that mediates phosphate transport across the membrane (26). PCP was initially identified in mitochondrial contact sites, but has also been found in the OMM (26, 27). Methotrexate binds to cytosolic dihydrofolate reductase (DHFR), so that addition of methotrexate during import of a mitochondrially targeted protein fused with DHFR at the C terminus will retain the protein at the OMM (28). To explore the potential role of PCP in StAR activity, we examined sheep adrenal mitochondrial import of [35S]StAR-DHFR (1-284 StAR + 2-224 DHFR) with or without methotrexate. Analysis of digitonin lysates of the StAR-DHFR complex on a 3-16% gradient native-PAGE revealed a band of about 140 kDa containing wild-type StAR, but not the inactive mutant, R182L StAR (Fig. 3A). In the absence of methotrexate StAR-DHFR formed a weak complex of lower apparent molecular weight (Fig. 3A). The complex resisted mild proteolysis with proteinase K (Fig. 3A), suggesting that StAR was bound tightly. Following sucrose gradient ultracentrifugation, the complex was found in fractions 7-11 and was resistant to proteinase K, whereas fractions 12-16 were digested (Fig. 3B) possibly indicating that they represented aggregates. The bands in fractions 7-11 were excised, digested with trypsin, and analyzed by mass spectrometry, identifying StAR, VDAC1, and PCP (29). In 6 experiments, 7 peptides corresponding to PCP were identified (Table 2); one peptide was seen in all 6 experiments (Fig. 3C); no differences were seen among fractions 7-11. Co-immunoprecipitation with antisera to VDAC1, StAR, and PCP confirmed the association of PCP and VDAC1 with StAR in fractions 7-11 (Fig. 3B). Antisera specific for VDAC residues 151-165, StAR, or PCP supershifted [35S]StAR from the complex (Fig. 3D), whereas preimmune serum or PBR antiserum did not, demonstrating specific association of StAR with VDAC1 and PCP. Immunoprecipitation of the digitonin extract with antibodies to StAR, VDAC1, and PCP independently confirmed the presence of these proteins in the complex (Fig. 3E).
###end p 35
###begin p 36
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 2</label>
###xml 7 39 7 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PCP peptides identified by MS/MS</bold>
###xml 7 39 7 39 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><bold>PCP peptides identified by MS/MS</bold></p>
###xml 39 339 39 339 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">The sequences obtained from sheep adrenal mitochondria were compared to the bovine sequence (Swiss Prot Accession number Q7Z7N7 (same as gb/AAH00998 and others)) as there is no sheep sequence in the database. The bold letters indicate unmatched residues, which may represent bovine-sheep differences.</p>
###xml 7 339 7 339 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37"><bold>PCP peptides identified by MS/MS</bold></p><p textid="38">The sequences obtained from sheep adrenal mitochondria were compared to the bovine sequence (Swiss Prot Accession number Q7Z7N7 (same as gb/AAH00998 and others)) as there is no sheep sequence in the database. The bold letters indicate unmatched residues, which may represent bovine-sheep differences.</p></caption>
###xml 339 347 339 347 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Position</bold>
###xml 339 347 339 347 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th>
###xml 347 353 347 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mol WT</bold>
###xml 347 353 347 353 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Mol WT</bold></th>
###xml 353 361 353 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence</bold>
###xml 353 361 353 361 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th>
###xml 339 361 339 361 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mol WT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr>
###xml 339 361 339 361 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mol WT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr></thead>
###xml 361 370 361 370 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 107-113 </td>
###xml 370 378 370 378 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 860.39 </td>
###xml 380 382 380 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 378 389 378 389 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>QVDPQK </td>
###xml 361 389 361 389 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"> 107-113 </td><td colspan="1" rowspan="1" align="center" valign="top"> 860.39 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>QVDPQK </td></tr>
###xml 389 398 389 398 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 310-318 </td>
###xml 398 406 398 406 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 875.47 </td>
###xml 412 413 412 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 406 417 406 417 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> GSSAS<bold>N</bold>VLK </td>
###xml 389 417 389 417 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"> 310-318 </td><td colspan="1" rowspan="1" align="center" valign="top"> 875.47 </td><td colspan="1" rowspan="1" align="left" valign="top"> GSSAS<bold>N</bold>VLK </td></tr>
###xml 417 426 417 426 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 221-228 </td>
###xml 426 435 426 435 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1012.49 </td>
###xml 437 439 437 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 435 447 435 447 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>YKEEGLK </td>
###xml 417 447 417 447 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"> 221-228 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1012.49 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>YKEEGLK </td></tr>
###xml 447 456 447 456 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 152-159 </td>
###xml 456 465 456 465 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1035.48 </td>
###xml 465 475 465 475 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> FGFYEVFK </td>
###xml 447 475 447 475 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"> 152-159 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1035.48 </td><td colspan="1" rowspan="1" align="left" valign="top"> FGFYEVFK </td></tr>
###xml 475 484 475 484 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 204-215 </td>
###xml 484 493 484 493 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1360.65 </td>
###xml 493 507 493 507 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> IQTQPGYANTLR </td>
###xml 475 507 475 507 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"> 204-215 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1360.65 </td><td colspan="1" rowspan="1" align="left" valign="top"> IQTQPGYANTLR </td></tr>
###xml 507 516 507 516 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 356-369 </td>
###xml 516 525 516 525 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1602.82 </td>
###xml 535 537 535 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ox</sub>
###xml 525 543 525 543 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> LPRPPPPEM<sub>ox</sub>PESLK </td>
###xml 507 543 507 543 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"> 356-369 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1602.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> LPRPPPPEM<sub>ox</sub>PESLK </td></tr>
###xml 543 550 543 550 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 66-77 </td>
###xml 550 559 550 559 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1491.59 </td>
###xml 568 569 568 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Y</bold>
###xml 559 574 559 574 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> AVEEYSCE<bold>Y</bold>GSAK </td>
###xml 543 574 543 574 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"> 66-77 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1491.59 </td><td colspan="1" rowspan="1" align="left" valign="top"> AVEEYSCE<bold>Y</bold>GSAK </td></tr>
###xml 361 574 361 574 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="center" valign="top"> 107-113 </td><td colspan="1" rowspan="1" align="center" valign="top"> 860.39 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>QVDPQK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 310-318 </td><td colspan="1" rowspan="1" align="center" valign="top"> 875.47 </td><td colspan="1" rowspan="1" align="left" valign="top"> GSSAS<bold>N</bold>VLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 221-228 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1012.49 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>YKEEGLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 152-159 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1035.48 </td><td colspan="1" rowspan="1" align="left" valign="top"> FGFYEVFK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 204-215 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1360.65 </td><td colspan="1" rowspan="1" align="left" valign="top"> IQTQPGYANTLR </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 356-369 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1602.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> LPRPPPPEM<sub>ox</sub>PESLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 66-77 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1491.59 </td><td colspan="1" rowspan="1" align="left" valign="top"> AVEEYSCE<bold>Y</bold>GSAK </td></tr></tbody>
###xml 339 574 339 574 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mol WT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="center" valign="top"> 107-113 </td><td colspan="1" rowspan="1" align="center" valign="top"> 860.39 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>QVDPQK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 310-318 </td><td colspan="1" rowspan="1" align="center" valign="top"> 875.47 </td><td colspan="1" rowspan="1" align="left" valign="top"> GSSAS<bold>N</bold>VLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 221-228 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1012.49 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>YKEEGLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 152-159 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1035.48 </td><td colspan="1" rowspan="1" align="left" valign="top"> FGFYEVFK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 204-215 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1360.65 </td><td colspan="1" rowspan="1" align="left" valign="top"> IQTQPGYANTLR </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 356-369 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1602.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> LPRPPPPEM<sub>ox</sub>PESLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 66-77 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1491.59 </td><td colspan="1" rowspan="1" align="left" valign="top"> AVEEYSCE<bold>Y</bold>GSAK </td></tr></tbody></table>
###xml 0 574 0 574 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl2"><label>TABLE 2</label><caption><p textid="37"><bold>PCP peptides identified by MS/MS</bold></p><p textid="38">The sequences obtained from sheep adrenal mitochondria were compared to the bovine sequence (Swiss Prot Accession number Q7Z7N7 (same as gb/AAH00998 and others)) as there is no sheep sequence in the database. The bold letters indicate unmatched residues, which may represent bovine-sheep differences.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Position</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mol WT</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Sequence</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="center" valign="top"> 107-113 </td><td colspan="1" rowspan="1" align="center" valign="top"> 860.39 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>QVDPQK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 310-318 </td><td colspan="1" rowspan="1" align="center" valign="top"> 875.47 </td><td colspan="1" rowspan="1" align="left" valign="top"> GSSAS<bold>N</bold>VLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 221-228 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1012.49 </td><td colspan="1" rowspan="1" align="left" valign="top"> M<sub>ox</sub>YKEEGLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 152-159 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1035.48 </td><td colspan="1" rowspan="1" align="left" valign="top"> FGFYEVFK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 204-215 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1360.65 </td><td colspan="1" rowspan="1" align="left" valign="top"> IQTQPGYANTLR </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 356-369 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1602.82 </td><td colspan="1" rowspan="1" align="left" valign="top"> LPRPPPPEM<sub>ox</sub>PESLK </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"> 66-77 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1491.59 </td><td colspan="1" rowspan="1" align="left" valign="top"> AVEEYSCE<bold>Y</bold>GSAK </td></tr></tbody></table></table-wrap>
###xml 67 72 <span type="species:ncbi:9940">sheep</span>
###xml 115 121 <span type="species:ncbi:9913">bovine</span>
###xml 216 221 <span type="species:ncbi:9940">sheep</span>
###xml 314 320 <span type="species:ncbi:9913">bovine</span>
###xml 321 326 <span type="species:ncbi:9940">sheep</span>
TABLE 2PCP peptides identified by MS/MSThe sequences obtained from sheep adrenal mitochondria were compared to the bovine sequence (Swiss Prot Accession number Q7Z7N7 (same as gb/AAH00998 and others)) as there is no sheep sequence in the database. The bold letters indicate unmatched residues, which may represent bovine-sheep differences.PositionMol WTSequence 107-113  860.39  MoxQVDPQK  310-318  875.47  GSSASNVLK  221-228  1012.49  MoxYKEEGLK  152-159  1035.48  FGFYEVFK  204-215  1360.65  IQTQPGYANTLR  356-369  1602.82  LPRPPPPEMoxPESLK  66-77  1491.59  AVEEYSCEYGSAK
###end p 36
###begin p 37
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PCP peptides identified by MS/MS</bold>
PCP peptides identified by MS/MS
###end p 37
###begin p 38
###xml 28 33 <span type="species:ncbi:9940">sheep</span>
###xml 76 82 <span type="species:ncbi:9913">bovine</span>
###xml 177 182 <span type="species:ncbi:9940">sheep</span>
###xml 275 281 <span type="species:ncbi:9913">bovine</span>
###xml 282 287 <span type="species:ncbi:9940">sheep</span>
The sequences obtained from sheep adrenal mitochondria were compared to the bovine sequence (Swiss Prot Accession number Q7Z7N7 (same as gb/AAH00998 and others)) as there is no sheep sequence in the database. The bold letters indicate unmatched residues, which may represent bovine-sheep differences.
###end p 38
###begin p 39
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 49 9 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Role of VDAC1 in pregnenolone synthesis.</bold>
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 147 154 147 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left. B</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 560 562 560 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 697 698 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 726 728 726 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 791 797 791 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 870 873 870 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 876 877 876 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1124 1125 1124 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1167 1174 1167 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel F</italic>
###xml 9 1215 9 1215 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><bold>Role of VDAC1 in pregnenolone synthesis.</bold><italic>A</italic>, Western blot of cytoplasm from VDAC1 knockdown COS-1 cells using the antisera indicated to the <italic>left. B</italic>, immunoprecipitation of StAR or phospho-StAR from VDAC1 knockdown COS-1 cells. <italic>C</italic>, COS-1 cells transfected with StAR were incubated with KPA, and lysates were immunoblotted with antisera to StAR and phospho-StAR. Blocking VDAC1 prevented processing of 32-kDa phospho-StAR to the 30-kDa form. <italic>D</italic>, pulse-chase experiments. COS-1 cells transfected with StAR were incubated in 30 mg/ml KPA, pulse labeled with [<sup>35</sup>S]methionine for 45 min, then chased with cold methionine for the indicated time and immunoprecipitated with the indicated antibodies. <italic>E</italic>, import kinetics of StAR. [<sup>35</sup>S]StAR was imported from 5 min to 2 h into COS-1 mitochondria (<italic>bottom</italic>) and compared with import into mitochondria from VDAC1 knockdown cells (<italic>top</italic>). <italic>F</italic>, activation of proteasomal proteases in the absence of VDAC1. Stably selected VDAC1 knockdown COS-1 cells were co-transfected with StAR and F2 and treated with the indicated protease inhibitors; StAR activity was restored by incubation with E64. <italic>G</italic>, immunoblotting of lysates from cells in <italic>panel F</italic> using antisera to StAR and phospho-StAR.</p>
###xml 9 1215 9 1215 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><bold>Role of VDAC1 in pregnenolone synthesis.</bold><italic>A</italic>, Western blot of cytoplasm from VDAC1 knockdown COS-1 cells using the antisera indicated to the <italic>left. B</italic>, immunoprecipitation of StAR or phospho-StAR from VDAC1 knockdown COS-1 cells. <italic>C</italic>, COS-1 cells transfected with StAR were incubated with KPA, and lysates were immunoblotted with antisera to StAR and phospho-StAR. Blocking VDAC1 prevented processing of 32-kDa phospho-StAR to the 30-kDa form. <italic>D</italic>, pulse-chase experiments. COS-1 cells transfected with StAR were incubated in 30 mg/ml KPA, pulse labeled with [<sup>35</sup>S]methionine for 45 min, then chased with cold methionine for the indicated time and immunoprecipitated with the indicated antibodies. <italic>E</italic>, import kinetics of StAR. [<sup>35</sup>S]StAR was imported from 5 min to 2 h into COS-1 mitochondria (<italic>bottom</italic>) and compared with import into mitochondria from VDAC1 knockdown cells (<italic>top</italic>). <italic>F</italic>, activation of proteasomal proteases in the absence of VDAC1. Stably selected VDAC1 knockdown COS-1 cells were co-transfected with StAR and F2 and treated with the indicated protease inhibitors; StAR activity was restored by incubation with E64. <italic>G</italic>, immunoblotting of lysates from cells in <italic>panel F</italic> using antisera to StAR and phospho-StAR.</p></caption>
###xml 1215 1215 1215 1215 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0170832510002"/>
###xml 0 1215 0 1215 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="40"><bold>Role of VDAC1 in pregnenolone synthesis.</bold><italic>A</italic>, Western blot of cytoplasm from VDAC1 knockdown COS-1 cells using the antisera indicated to the <italic>left. B</italic>, immunoprecipitation of StAR or phospho-StAR from VDAC1 knockdown COS-1 cells. <italic>C</italic>, COS-1 cells transfected with StAR were incubated with KPA, and lysates were immunoblotted with antisera to StAR and phospho-StAR. Blocking VDAC1 prevented processing of 32-kDa phospho-StAR to the 30-kDa form. <italic>D</italic>, pulse-chase experiments. COS-1 cells transfected with StAR were incubated in 30 mg/ml KPA, pulse labeled with [<sup>35</sup>S]methionine for 45 min, then chased with cold methionine for the indicated time and immunoprecipitated with the indicated antibodies. <italic>E</italic>, import kinetics of StAR. [<sup>35</sup>S]StAR was imported from 5 min to 2 h into COS-1 mitochondria (<italic>bottom</italic>) and compared with import into mitochondria from VDAC1 knockdown cells (<italic>top</italic>). <italic>F</italic>, activation of proteasomal proteases in the absence of VDAC1. Stably selected VDAC1 knockdown COS-1 cells were co-transfected with StAR and F2 and treated with the indicated protease inhibitors; StAR activity was restored by incubation with E64. <italic>G</italic>, immunoblotting of lysates from cells in <italic>panel F</italic> using antisera to StAR and phospho-StAR.</p></caption><graphic xlink:href="zbc0170832510002"/></fig>
FIGURE 2.Role of VDAC1 in pregnenolone synthesis.A, Western blot of cytoplasm from VDAC1 knockdown COS-1 cells using the antisera indicated to the left. B, immunoprecipitation of StAR or phospho-StAR from VDAC1 knockdown COS-1 cells. C, COS-1 cells transfected with StAR were incubated with KPA, and lysates were immunoblotted with antisera to StAR and phospho-StAR. Blocking VDAC1 prevented processing of 32-kDa phospho-StAR to the 30-kDa form. D, pulse-chase experiments. COS-1 cells transfected with StAR were incubated in 30 mg/ml KPA, pulse labeled with [35S]methionine for 45 min, then chased with cold methionine for the indicated time and immunoprecipitated with the indicated antibodies. E, import kinetics of StAR. [35S]StAR was imported from 5 min to 2 h into COS-1 mitochondria (bottom) and compared with import into mitochondria from VDAC1 knockdown cells (top). F, activation of proteasomal proteases in the absence of VDAC1. Stably selected VDAC1 knockdown COS-1 cells were co-transfected with StAR and F2 and treated with the indicated protease inhibitors; StAR activity was restored by incubation with E64. G, immunoblotting of lysates from cells in panel F using antisera to StAR and phospho-StAR.
###end p 39
###begin p 40
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Role of VDAC1 in pregnenolone synthesis.</bold>
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left. B</italic>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 551 553 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 688 689 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 717 719 717 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 861 864 861 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 867 868 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1115 1116 1115 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1158 1165 1158 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel F</italic>
Role of VDAC1 in pregnenolone synthesis.A, Western blot of cytoplasm from VDAC1 knockdown COS-1 cells using the antisera indicated to the left. B, immunoprecipitation of StAR or phospho-StAR from VDAC1 knockdown COS-1 cells. C, COS-1 cells transfected with StAR were incubated with KPA, and lysates were immunoblotted with antisera to StAR and phospho-StAR. Blocking VDAC1 prevented processing of 32-kDa phospho-StAR to the 30-kDa form. D, pulse-chase experiments. COS-1 cells transfected with StAR were incubated in 30 mg/ml KPA, pulse labeled with [35S]methionine for 45 min, then chased with cold methionine for the indicated time and immunoprecipitated with the indicated antibodies. E, import kinetics of StAR. [35S]StAR was imported from 5 min to 2 h into COS-1 mitochondria (bottom) and compared with import into mitochondria from VDAC1 knockdown cells (top). F, activation of proteasomal proteases in the absence of VDAC1. Stably selected VDAC1 knockdown COS-1 cells were co-transfected with StAR and F2 and treated with the indicated protease inhibitors; StAR activity was restored by incubation with E64. G, immunoblotting of lysates from cells in panel F using antisera to StAR and phospho-StAR.
###end p 40
###begin p 41
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Role of PCP in StAR Activity</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 180 187 180 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 651 658 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 966 967 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 960 967 960 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1150 1151 1150 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1144 1151 1144 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 1207 1208 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1201 1208 1201 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 1315 1316 1315 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1329 1331 1329 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 1357 1359 1357 1359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1373 1374 1373 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1367 1374 1367 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 1474 1476 1474 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 1507 1508 1507 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1658 1659 1658 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1652 1659 1652 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 1673 1675 1673 1675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1743 1744 1743 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1768 1769 1768 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1891 1892 1891 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1885 1892 1885 1892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>F</italic></xref>
Role of PCP in StAR Activity-PCP knockdown by siRNA reduced expression of PCP and phospho-StAR, partially reduced expression of the 30-kDa dephospho-StAR but did not affect VDAC1 (Fig. 4A). This PCP knockdown in cells cotransfected with StAR and F2 blocked pregnenolone synthesis (Fig. 4B), suggesting that PCP is essential for maintaining phosphorylated StAR. To determine whether PCP stimulates ATP levels, we examined the effect of ATP on StAR activity by depleting ATP via serum starvation or drug inhibition, in contrast to supplementing with exogenously added ATP. VDAC1 knockdown decreased intracellular ATP to 40% compared with control cells (Fig. 4C), but exogenously added ATP did not restore StAR activity (not shown). Depletion of PCP or serum starving the cells for 48 h reduced ATP levels to 10%. A similar reduction in ATP was seen after incubating cells with the ATP inhibitor 2-deoxyglucose or the electron transport inhibitor, rotenone (30) (Fig. 4C). As expected, incubation with rotenone or 2-deoxyglucose reduced pregnenolone synthesis similarly to knockdown of VDAC1 or PCP in COS-1 cells co-transfected with StAR and F2 (Fig. 4D). Consistent with the PCP knockdown experiments (Fig. 4A), preincubation of mitochondria with the irreversible mitochondrial phosphate carrier inhibitors, PITC or p-sulfo-PITC (31), blocked the import of [35S]StAR (Fig. 4E). Similar results were obtained in response to mersalyl, a reversible sulfhydryl blocking reagent (31). The addition of mersalyl to p-sulfo-PITC-treated mitochondria did not rescue StAR import, but StAR import was restored by adding ATP to mitochondria preincubated with PITC (Fig. 4E). Import of [35S]StAR into isolated mitochondria was inhibited by carbonyl cyanide m-chlorophenylhydrazone (mCCCP), which disrupts mitochondrial membrane potential, but was not inhibited by bongkrekic acid and atractyloside (Fig. 4F), suggesting that ANT does not participate in StAR activity or import. These results indicate that PCP regulates phosphate availability needed for StAR phosphorylation. PCP appears to function upstream of VDAC1, as the absence of VADC1 did not completely eliminate ATP.
###end p 41
###begin p 42
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 86 9 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Characterization of phosphate carrier protein associated in the StAR complex.</bold>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 324 326 324 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PK</italic>
###xml 359 367 359 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right. B</italic>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 477 486 477 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Top panel</italic>
###xml 561 573 561 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Second panel</italic>
###xml 650 659 650 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top panel</italic>
###xml 725 732 725 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7</italic>
###xml 736 738 736 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">11</italic>
###xml 768 773 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Third</italic>
###xml 777 789 777 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fifth panels</italic>
###xml 905 906 905 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 994 995 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1191 1192 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 9 1334 9 1334 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><bold>Characterization of phosphate carrier protein associated in the StAR complex.</bold><italic>A</italic>, native gel electrophoresis of digitonin extract following import of [<sup>35</sup>S]StAR into isolated mitochondria. StAR, but not the inactive StAR mutant R182L, forms a 140-kDa complex, which is resistant to mild proteolysis with proteinase K (<italic>PK</italic>). Size markers are shown to the <italic>right. B</italic>, sucrose density gradient analysis of the 140-kDa complex. Size markers are shown to the <italic>left</italic> in all panels. <italic>Top panel</italic>, autoradiogram of gradient native-PAGE gel of sucrose gradient fractions. <italic>Second panel</italic>, SDS-PAGE gel of fractions from the same amount of protein displayed in the <italic>top panel</italic> subjected to mild proteolysis with PK. The purified complex from <italic>lanes 7</italic> to <italic>11</italic> is resistant to proteolysis. <italic>Third</italic> to <italic>fifth panels</italic>, immunoprecipitation of the sucrose density gradient fractions with the indicated antibodies followed by SDS-PAGE. <italic>C</italic>, mass spectrometric identification of the predominant peptide, showing it is from PCP. <italic>D</italic>, antibody shifts of the digitonin extract of the 140-kDa complex. The digitonin-extracted complex was incubated with the indicated antibodies and analyzed by native gradient gel electrophoresis. <italic>E</italic>, immunoprecipitation. The digitonin-extracted 140-kDa complex was immunoprecipitated with the indicated antibodies and separated by SDS-PAGE.</p>
###xml 9 1334 9 1334 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43"><bold>Characterization of phosphate carrier protein associated in the StAR complex.</bold><italic>A</italic>, native gel electrophoresis of digitonin extract following import of [<sup>35</sup>S]StAR into isolated mitochondria. StAR, but not the inactive StAR mutant R182L, forms a 140-kDa complex, which is resistant to mild proteolysis with proteinase K (<italic>PK</italic>). Size markers are shown to the <italic>right. B</italic>, sucrose density gradient analysis of the 140-kDa complex. Size markers are shown to the <italic>left</italic> in all panels. <italic>Top panel</italic>, autoradiogram of gradient native-PAGE gel of sucrose gradient fractions. <italic>Second panel</italic>, SDS-PAGE gel of fractions from the same amount of protein displayed in the <italic>top panel</italic> subjected to mild proteolysis with PK. The purified complex from <italic>lanes 7</italic> to <italic>11</italic> is resistant to proteolysis. <italic>Third</italic> to <italic>fifth panels</italic>, immunoprecipitation of the sucrose density gradient fractions with the indicated antibodies followed by SDS-PAGE. <italic>C</italic>, mass spectrometric identification of the predominant peptide, showing it is from PCP. <italic>D</italic>, antibody shifts of the digitonin extract of the 140-kDa complex. The digitonin-extracted complex was incubated with the indicated antibodies and analyzed by native gradient gel electrophoresis. <italic>E</italic>, immunoprecipitation. The digitonin-extracted 140-kDa complex was immunoprecipitated with the indicated antibodies and separated by SDS-PAGE.</p></caption>
###xml 1334 1334 1334 1334 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0170832510003"/>
###xml 0 1334 0 1334 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="43"><bold>Characterization of phosphate carrier protein associated in the StAR complex.</bold><italic>A</italic>, native gel electrophoresis of digitonin extract following import of [<sup>35</sup>S]StAR into isolated mitochondria. StAR, but not the inactive StAR mutant R182L, forms a 140-kDa complex, which is resistant to mild proteolysis with proteinase K (<italic>PK</italic>). Size markers are shown to the <italic>right. B</italic>, sucrose density gradient analysis of the 140-kDa complex. Size markers are shown to the <italic>left</italic> in all panels. <italic>Top panel</italic>, autoradiogram of gradient native-PAGE gel of sucrose gradient fractions. <italic>Second panel</italic>, SDS-PAGE gel of fractions from the same amount of protein displayed in the <italic>top panel</italic> subjected to mild proteolysis with PK. The purified complex from <italic>lanes 7</italic> to <italic>11</italic> is resistant to proteolysis. <italic>Third</italic> to <italic>fifth panels</italic>, immunoprecipitation of the sucrose density gradient fractions with the indicated antibodies followed by SDS-PAGE. <italic>C</italic>, mass spectrometric identification of the predominant peptide, showing it is from PCP. <italic>D</italic>, antibody shifts of the digitonin extract of the 140-kDa complex. The digitonin-extracted complex was incubated with the indicated antibodies and analyzed by native gradient gel electrophoresis. <italic>E</italic>, immunoprecipitation. The digitonin-extracted 140-kDa complex was immunoprecipitated with the indicated antibodies and separated by SDS-PAGE.</p></caption><graphic xlink:href="zbc0170832510003"/></fig>
FIGURE 3.Characterization of phosphate carrier protein associated in the StAR complex.A, native gel electrophoresis of digitonin extract following import of [35S]StAR into isolated mitochondria. StAR, but not the inactive StAR mutant R182L, forms a 140-kDa complex, which is resistant to mild proteolysis with proteinase K (PK). Size markers are shown to the right. B, sucrose density gradient analysis of the 140-kDa complex. Size markers are shown to the left in all panels. Top panel, autoradiogram of gradient native-PAGE gel of sucrose gradient fractions. Second panel, SDS-PAGE gel of fractions from the same amount of protein displayed in the top panel subjected to mild proteolysis with PK. The purified complex from lanes 7 to 11 is resistant to proteolysis. Third to fifth panels, immunoprecipitation of the sucrose density gradient fractions with the indicated antibodies followed by SDS-PAGE. C, mass spectrometric identification of the predominant peptide, showing it is from PCP. D, antibody shifts of the digitonin extract of the 140-kDa complex. The digitonin-extracted complex was incubated with the indicated antibodies and analyzed by native gradient gel electrophoresis. E, immunoprecipitation. The digitonin-extracted 140-kDa complex was immunoprecipitated with the indicated antibodies and separated by SDS-PAGE.
###end p 42
###begin p 43
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Characterization of phosphate carrier protein associated in the StAR complex.</bold>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 315 317 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PK</italic>
###xml 350 358 350 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right. B</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 468 477 468 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Top panel</italic>
###xml 552 564 552 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Second panel</italic>
###xml 641 650 641 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top panel</italic>
###xml 716 723 716 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 7</italic>
###xml 727 729 727 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">11</italic>
###xml 759 764 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Third</italic>
###xml 768 780 768 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fifth panels</italic>
###xml 896 897 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 985 986 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1182 1183 1182 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
Characterization of phosphate carrier protein associated in the StAR complex.A, native gel electrophoresis of digitonin extract following import of [35S]StAR into isolated mitochondria. StAR, but not the inactive StAR mutant R182L, forms a 140-kDa complex, which is resistant to mild proteolysis with proteinase K (PK). Size markers are shown to the right. B, sucrose density gradient analysis of the 140-kDa complex. Size markers are shown to the left in all panels. Top panel, autoradiogram of gradient native-PAGE gel of sucrose gradient fractions. Second panel, SDS-PAGE gel of fractions from the same amount of protein displayed in the top panel subjected to mild proteolysis with PK. The purified complex from lanes 7 to 11 is resistant to proteolysis. Third to fifth panels, immunoprecipitation of the sucrose density gradient fractions with the indicated antibodies followed by SDS-PAGE. C, mass spectrometric identification of the predominant peptide, showing it is from PCP. D, antibody shifts of the digitonin extract of the 140-kDa complex. The digitonin-extracted complex was incubated with the indicated antibodies and analyzed by native gradient gel electrophoresis. E, immunoprecipitation. The digitonin-extracted 140-kDa complex was immunoprecipitated with the indicated antibodies and separated by SDS-PAGE.
###end p 43
###begin title 44
DISCUSSION
###end title 44
###begin p 45
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">195</sup>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
Despite extensive study, the mechanism of StAR action remains unclear. StAR acts exclusively on the OMM prior to import (3), must undergo a structural transition to exert activity (9, 32), and phosphorylation of Ser195 augments its steroidogenic activity (4). The ability of StAR to transfer cholesterol between membranes is distinct from its ability to induce steroidogenesis (33). The proposal that StAR acts through an OMM receptor was challenged by data showing it had activity with mitochondria subjected to proteolysis (34). Nevertheless, substantial data suggest that cholesterol import into mitochondria requires the 18-kDa PBR on the OMM. PBR has five transmembrane domains; its N terminus binds benzodiazepines that stimulate steroidogenesis and its C terminus binds cholesterol (7). A functional association with StAR is indicated by the loss of StAR activity in PBR-knockdown cells (8). Several proteins appear to interact with PBR, including VDAC1 and ANT (21), a 10-kDa protein (35), PRAX-1 (36), and PBR-associated protein 7 (PAP7) (37). Photoaffinity labeled PBR forms a complex of 170-210 kDa (38) or 200-240 kDa (39), but these complexes did not include StAR. Therefore the nature of the StAR receptor has been unclear. We have now shown that StAR directly interacts with VDAC1 and PCP on the OMM.
###end p 45
###begin p 46
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 69 9 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Role of phosphate carrier protein in pregnenolone synthesis.</bold>
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 118 125 118 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel B</italic>
###xml 181 184 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCP</italic>
###xml 217 218 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 324 325 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 376 377 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 554 555 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 810 811 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 862 863 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 876 878 872 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 938 940 934 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p-</italic>
###xml 1090 1091 1086 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1093 1095 1089 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1351 1358 1347 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, C, D</italic>
###xml 1364 1365 1360 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 9 1457 9 1451 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47"><bold>Role of phosphate carrier protein in pregnenolone synthesis.</bold><italic>A</italic>, Western blot. Lysates collected from cells in <italic>panel B</italic> were immunoblotted with the indicated antibodies; &#916;<italic>PCP</italic> denotes PCP knockdown by siRNA. <italic>B</italic>, pregnenolone synthesis by PCP knockdown COS-1 cells co-transfected with StAR and F2. Incubation with 22(<italic>R</italic>)-hydroxycholesterol served as a positive control. <italic>C</italic>, measurement of ATP in untreated VDAC1 knockdown or PCP knockdown COS-1 cells expressing StAR and F2, and in serum-starved COS-1 cells treated with 2-deoxyglucose or rotenone. <italic>D</italic>, measurement of pregnenolone synthesis in COS-1 cells transfected with StAR and F2 that were serum starved, then treated with 2-deoxyglucose or rotenone. PCP and VDAC1 knockdown cells served as negative controls, and F2-transfected cells treated with 22(<italic>R</italic>)-hydroxycholesterol served as a positive control. <italic>E</italic>, import of [<sup>35</sup>S]StAR after blocking ATP transport with mersalyl, PITC, or <italic>p-</italic>sulfo-PITC. The import of StAR was interrupted by blocking PCP with PITC; the addition of exogenous ATP restored StAR import in the presence of PITC. <italic>F</italic>,[<sup>35</sup>S]StAR was imported into isolated mitochondria in the presence and absence of mCCCP, bongkrekic acid, or atractylosidase. The intensity of the imported 30-kDa band was measured by phosphorimager and plotted against the concentrations of the drugs. Data in <italic>A, C, D</italic>, and <italic>F</italic> are expressed as mean &#177; S.E. of three separate experiments, each performed in triplicate.</p>
###xml 9 1457 9 1451 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="47"><bold>Role of phosphate carrier protein in pregnenolone synthesis.</bold><italic>A</italic>, Western blot. Lysates collected from cells in <italic>panel B</italic> were immunoblotted with the indicated antibodies; &#916;<italic>PCP</italic> denotes PCP knockdown by siRNA. <italic>B</italic>, pregnenolone synthesis by PCP knockdown COS-1 cells co-transfected with StAR and F2. Incubation with 22(<italic>R</italic>)-hydroxycholesterol served as a positive control. <italic>C</italic>, measurement of ATP in untreated VDAC1 knockdown or PCP knockdown COS-1 cells expressing StAR and F2, and in serum-starved COS-1 cells treated with 2-deoxyglucose or rotenone. <italic>D</italic>, measurement of pregnenolone synthesis in COS-1 cells transfected with StAR and F2 that were serum starved, then treated with 2-deoxyglucose or rotenone. PCP and VDAC1 knockdown cells served as negative controls, and F2-transfected cells treated with 22(<italic>R</italic>)-hydroxycholesterol served as a positive control. <italic>E</italic>, import of [<sup>35</sup>S]StAR after blocking ATP transport with mersalyl, PITC, or <italic>p-</italic>sulfo-PITC. The import of StAR was interrupted by blocking PCP with PITC; the addition of exogenous ATP restored StAR import in the presence of PITC. <italic>F</italic>,[<sup>35</sup>S]StAR was imported into isolated mitochondria in the presence and absence of mCCCP, bongkrekic acid, or atractylosidase. The intensity of the imported 30-kDa band was measured by phosphorimager and plotted against the concentrations of the drugs. Data in <italic>A, C, D</italic>, and <italic>F</italic> are expressed as mean &#177; S.E. of three separate experiments, each performed in triplicate.</p></caption>
###xml 1457 1457 1451 1451 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0170832510004"/>
###xml 0 1457 0 1451 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="47"><bold>Role of phosphate carrier protein in pregnenolone synthesis.</bold><italic>A</italic>, Western blot. Lysates collected from cells in <italic>panel B</italic> were immunoblotted with the indicated antibodies; &#916;<italic>PCP</italic> denotes PCP knockdown by siRNA. <italic>B</italic>, pregnenolone synthesis by PCP knockdown COS-1 cells co-transfected with StAR and F2. Incubation with 22(<italic>R</italic>)-hydroxycholesterol served as a positive control. <italic>C</italic>, measurement of ATP in untreated VDAC1 knockdown or PCP knockdown COS-1 cells expressing StAR and F2, and in serum-starved COS-1 cells treated with 2-deoxyglucose or rotenone. <italic>D</italic>, measurement of pregnenolone synthesis in COS-1 cells transfected with StAR and F2 that were serum starved, then treated with 2-deoxyglucose or rotenone. PCP and VDAC1 knockdown cells served as negative controls, and F2-transfected cells treated with 22(<italic>R</italic>)-hydroxycholesterol served as a positive control. <italic>E</italic>, import of [<sup>35</sup>S]StAR after blocking ATP transport with mersalyl, PITC, or <italic>p-</italic>sulfo-PITC. The import of StAR was interrupted by blocking PCP with PITC; the addition of exogenous ATP restored StAR import in the presence of PITC. <italic>F</italic>,[<sup>35</sup>S]StAR was imported into isolated mitochondria in the presence and absence of mCCCP, bongkrekic acid, or atractylosidase. The intensity of the imported 30-kDa band was measured by phosphorimager and plotted against the concentrations of the drugs. Data in <italic>A, C, D</italic>, and <italic>F</italic> are expressed as mean &#177; S.E. of three separate experiments, each performed in triplicate.</p></caption><graphic xlink:href="zbc0170832510004"/></fig>
FIGURE 4.Role of phosphate carrier protein in pregnenolone synthesis.A, Western blot. Lysates collected from cells in panel B were immunoblotted with the indicated antibodies; DeltaPCP denotes PCP knockdown by siRNA. B, pregnenolone synthesis by PCP knockdown COS-1 cells co-transfected with StAR and F2. Incubation with 22(R)-hydroxycholesterol served as a positive control. C, measurement of ATP in untreated VDAC1 knockdown or PCP knockdown COS-1 cells expressing StAR and F2, and in serum-starved COS-1 cells treated with 2-deoxyglucose or rotenone. D, measurement of pregnenolone synthesis in COS-1 cells transfected with StAR and F2 that were serum starved, then treated with 2-deoxyglucose or rotenone. PCP and VDAC1 knockdown cells served as negative controls, and F2-transfected cells treated with 22(R)-hydroxycholesterol served as a positive control. E, import of [35S]StAR after blocking ATP transport with mersalyl, PITC, or p-sulfo-PITC. The import of StAR was interrupted by blocking PCP with PITC; the addition of exogenous ATP restored StAR import in the presence of PITC. F,[35S]StAR was imported into isolated mitochondria in the presence and absence of mCCCP, bongkrekic acid, or atractylosidase. The intensity of the imported 30-kDa band was measured by phosphorimager and plotted against the concentrations of the drugs. Data in A, C, D, and F are expressed as mean +/- S.E. of three separate experiments, each performed in triplicate.
###end p 46
###begin p 47
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Role of phosphate carrier protein in pregnenolone synthesis.</bold>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 109 116 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel B</italic>
###xml 172 175 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCP</italic>
###xml 208 209 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 315 316 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 367 368 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 545 546 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 801 802 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 853 854 849 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 867 869 863 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 929 931 925 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p-</italic>
###xml 1081 1082 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1084 1086 1080 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1342 1349 1338 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, C, D</italic>
###xml 1355 1356 1351 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
Role of phosphate carrier protein in pregnenolone synthesis.A, Western blot. Lysates collected from cells in panel B were immunoblotted with the indicated antibodies; DeltaPCP denotes PCP knockdown by siRNA. B, pregnenolone synthesis by PCP knockdown COS-1 cells co-transfected with StAR and F2. Incubation with 22(R)-hydroxycholesterol served as a positive control. C, measurement of ATP in untreated VDAC1 knockdown or PCP knockdown COS-1 cells expressing StAR and F2, and in serum-starved COS-1 cells treated with 2-deoxyglucose or rotenone. D, measurement of pregnenolone synthesis in COS-1 cells transfected with StAR and F2 that were serum starved, then treated with 2-deoxyglucose or rotenone. PCP and VDAC1 knockdown cells served as negative controls, and F2-transfected cells treated with 22(R)-hydroxycholesterol served as a positive control. E, import of [35S]StAR after blocking ATP transport with mersalyl, PITC, or p-sulfo-PITC. The import of StAR was interrupted by blocking PCP with PITC; the addition of exogenous ATP restored StAR import in the presence of PITC. F,[35S]StAR was imported into isolated mitochondria in the presence and absence of mCCCP, bongkrekic acid, or atractylosidase. The intensity of the imported 30-kDa band was measured by phosphorimager and plotted against the concentrations of the drugs. Data in A, C, D, and F are expressed as mean +/- S.E. of three separate experiments, each performed in triplicate.
###end p 47
###begin p 48
###xml 398 400 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 458 460 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 694 696 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 1028 1030 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 1072 1073 1064 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 1011 1015 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
These observations are wholly consistent with the literature implicating PBR in the action of StAR to induce steroidogenesis. The association with PCP is consistent with the need to phosphorylate StAR to achieve maximal activity. StAR appears to be phosphorylated by PKA, and PAP7 appears to act as an anchoring protein to promote the interaction of PBR and PKA regulatory subunit 1a (PKAR1alpha) (37). PCP may play a role in delivering phosphate to PKAR1a (27). Only the cytoplasmically exposed domains of VDAC1 interacted with StAR, and the C terminus of StAR formed contacts with VDAC1, consistent with data that this domain of StAR also interacts with synthetic membrane models of the OMM (40). We suggest that StAR acts by interacting with VDAC1, which is part of a larger OMM complex including StAR, VDAC1, PCP, PBR, PAP7, PKAR1alpha, and possibly other proteins. It remains unclear whether VDAC1 forms the channel through which cholesterol passes or if this function is served by PBR. As VDAC1 knock-out mice are viable (41) but PBR knockouts are embryonic lethal (7), we suggest that the channel is formed by PBR in association with other proteins.
###end p 48
###begin p 49
We thank Dr. Charles Wood for adrenal tissues, Dr. Marco Colombini for the Koenig's polyanion and for reviewing an earlier version of this manuscript, Dr. Steven King for the phospho-StAR antibody, Dr. Vivian Aires for VDAC2 antibody, and Drs. Stanly Korsemeyer, Nikolas Pfanner, Carla Koehler, Debkumar Pain, and Andreas Matouscheck for providing various plasmids.
###end p 49
###begin p 50
The abbreviations used are: StAR, steroidogenic acute regulatory protein; OMM, outer mitochondrial membrane; IMM, inner membrane; VDAC1, voltage-dependent anion channel 1; PCP, phosphate carrier protein; PBR, peripheral benzodiazepine receptor; MS, mass spectrometry; KPA, Koenig's polyanion; PITC, phenylisothiocyanate; siRNA, small interfering RNA; DHFR, dihydrofolate reductase; ANT, adenine nucleotide transporter; PKA, protein kinase A; BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl) propane-1,3-diol.
###end p 50

